Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series ; volume:18 ; number:1 ; day:1 ; month:2 ; year:2017 ; pages:1-10 ; date:12.2017
BMC nephrology ; 18, Heft 1 (1.2.2017), 1-10, 12.2017
- Creator
-
Cortazar, Frank B.
- Contributor
-
Leaf, David E.
Owens, Charles T.
Laliberte, Karen
Pendergraft, William F.
Niles, John L.
SpringerLink (Online service)
- DOI
-
10.1186/s12882-017-0459-z
- URN
-
urn:nbn:de:101:1-2018091512181304419722
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cortazar, Frank B.
- Leaf, David E.
- Owens, Charles T.
- Laliberte, Karen
- Pendergraft, William F.
- Niles, John L.
- SpringerLink (Online service)
Other Objects (12)
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis
Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
Lupus Membranous Nephropathy
Perspectives in membranous nephropathy
Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
C4d immunohistochemistry in membranous nephropathy
Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London
Antigen-specific therapies of membranous nephropathy
Efficacy and safety of rituximab in patients with PLA2R associated membranous nephropathy and resolved HCV infection
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis
Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
Lupus Membranous Nephropathy
Perspectives in membranous nephropathy
Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
C4d immunohistochemistry in membranous nephropathy
Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London
Antigen-specific therapies of membranous nephropathy
Efficacy and safety of rituximab in patients with PLA2R associated membranous nephropathy and resolved HCV infection
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis
Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
Lupus Membranous Nephropathy
Perspectives in membranous nephropathy
Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
C4d immunohistochemistry in membranous nephropathy
Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London
Antigen-specific therapies of membranous nephropathy